Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 RESEARCH SCOPE 
           1.3.1 MARKET COVERED
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY 
    1.5 LIMITATIONS 
    1.6 MAJOR MARKET STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH DESIGN 
           2.2.1 SECONDARY RESEARCH
           2.2.2 PRIMARY RESEARCH
                    2.2.2.1 PRIMARY SOURCES
                    2.2.2.2 KEY INDUSTRY INSIGHTS
                    2.2.2.3 BREAKDOWN OF PRIMARIES
    2.3 IMPACT OF RECESSION ON MULTIMODAL IMAGING MARKET 
    2.4 MARKET SIZE ESTIMATION 
           2.4.1 REVENUE-MAPPING BASED MARKET ESTIMATION
           2.4.2 PROCEDURE BASED MARKET ESTIMATION
           2.4.2 PRIMARY RESEARCH VALIDATION
    2.5 DATA TRIANGULATION APPROACH 
    2.6 RESEARCH ASSUMPTIONS AND LIMITATIONS 
           2.6.1 RESEARCH ASSUMPTIONS
           2.6.2 RESEARCH LIMITATIONS
    2.7 RISK ASSESSMENT 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 MARKET DYNAMICS  
           5.1.1 DRIVERS
           5.1.2 RESTRAINTS
           5.1.3 KEY GROWTH OPPORTUNITIES
           5.1.4 INDUSTRY-SPECIFIC CHALLENGES
    5.2 PORTER’S FIVE FORCES ANALYSIS 
    5.3 REGULATORY LANDSCAPE  
           5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
           5.3.2 REGULATORY TRENDS
    5.4 REIMBURSEMENT SCENARIO  
    5.5 ECOSYSTEM COVERAGE 
    5.6 VALUE CHAIN ANALYSIS  
    5.7 SUPPLY CHAIN ANALYSIS 
    5.8 PRICING ANALYSIS  
           5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
           5.8.2 AVERAGE SELLING PRICE TREND
    5.9 PATENT ANALYSIS 
    5.10 TRADE ANALYSIS 
    5.11 TECHNOLOGY ANALYSIS 
    5.12 KEY CONFERENCES & EVENTS IN 2023-2024 
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS
           5.14.2 BUYING CRITERIA
    5.15 CASE STUDY ANALYSIS 
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY (USD MILLION; 2021—2028)*  
    6.1 PET/CT SYSTEMS  
    6.2 SPECT/CT SYSTEMS 
    6.3 PET/MR SYSTEMS 
    6.4 OCT/FLUORESCENCE MOLECULAR TOMOGRAPHY (FMT) 
    6.5 MR/OPTICAL IMAGING  
    6.6 OTHER MULTIMODAL SYSTEMS 
7 MULTIMODAL IMAGING MARKET, BY APPLICATION (USD MILLION; 2021—2028)* 
    7.1 BRAIN AND NEUROLOGY 
    7.2 CARDIOLOGY 
    7.3 ONCOLOGY 
    7.4 OPHTHALMOLOGY 
    7.5 RESEARCH APPLICATIONS 
    7.6 OTHER APPLICATIONS 
8 MULTIMODAL IMAGING MARKET, BY END-USER (USD MILLION; 2021—2028)* 
    8.1 HOSPITALS 
    8.2 DIAGNOSTIC IMAGING CENTERS 
    8.3 ACADEMIC AND RESEARCH INSTITUTES 
    8.4 OTHER END USERS 
9 MULTIMODAL IMAGING MARKET, BY REGION (USD MILLION; 2021—2028) 
    9.1 INTRODUCTION 
    9.2 NORTH AMERICA 
           9.2.1 RECESSION IMPACT
           9.2.2 US
           9.2.3 CANADA 
    9.3 EUROPE  
           9.3.1 RECESSION IMPACT
           9.3.2 GERMANY
           9.3.3 UK
           9.3.3 FRANCE
           9.3.5 ITALY 
           9.3.6 SPAIN
           9.3.7 REST OF EUROPE
    9.4 ASIA-PACIFIC 
           9.4.1 RECESSION IMPACT
           9.4.2 JAPAN 
           9.4.3 CHINA 
           9.4.4 INDIA 
           9.4.5 SOUTH KOREA 
           9.4.6 AUSTRALIA 
           9.4.7 REST OF ASIA-PACIFIC
    9.5 LATIN AMERICA 
           9.5.1 RECESSION IMPACT
           9.5.2 BRAZIL 
           9.5.3 MEXICO 
           9.5.4 REST OF LATIN AMERICA 
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 RECESSION IMPACT
10  COMPETITIVE LANDSCAPE  
     10.1 INTRODUCTION 
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2023) 
     10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 
     10.4 MARKET SHARE ANALYSIS-2022 
     10.5 COMPANY EVALUATION MATRIX 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS 
     10.6 START-UP/SME EVALUATION MATRIX 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 RESPONSIVE COMPANIES
             10.6.3 DYNAMIC COMPANIES
             10.6.4 STARTING BLOCKS  
     10.7 C0MPETITIVE SITUATION AND TRENDS (2021-2023) 
             10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
             10.7.2 DEALS
             10.7.3 OTHER DEVELOPMENTS
     10.8 COMPETITIVE BENCHMARKING 
11 COMPANY PROFILES** 
(Business Overview, Products Offered, Industry-specific Developments for 2021-2022)***
     11.1 GE HEALTHCARE 
     11.2 KONINKLIJKE PHILIPS N.V. 
     11.3 CANON MEDICAL SYSTEM CORPORATION 
     11.4 SIEMENS HELATHINEERS AG 
     11.5 UNITED IMAGING HEALTHCARE CO., LTD. 
     11.6 NEUSOFT CORPORATION 
     11.7 MEDISO LTD. 
     11.8 SPECTRUM DYNAMICS MEDICAL. 
     11.9 INFRAREDX, INC. 
     11.10 TOPCON CORPORATION 
     11.11 CARL ZEISS AG 
     11.12 HEIDELBERG ENGINEERING 
     11.13 BRUKER CORPORATION 
     11.14 PERKINELMER, INC 
     11.15 IBM CORPORATION 
     11.16 ESAOTE S.P.A. 
     11.17 FONAR CORP 
     11.18 ECHO-SON S.A. 
     11.19 POSITRON CORPORATION 
     11.20 MILABS B.V. 
     11.21 TOSHIBA CORPORATION. 
12 APPENDIX